chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a now "9 year old" female patient who in "2001" and in 2007 was vaccinated with the first and the second doses of VARIVAX (Merck), respectively. Subsequently, the patient experienced a mild breakthrough of chicken pox. The pox was on the torso and legs. They were popping out as the patient was in the office. No lot or expiration date was provided. The patient sought unspecified medical attention. At the time of the report, the patient's outcome was unspecified. Follow up information has been received from a physician concerning the 10 months old female student with no illness at time of vaccination who on 25-OCT-2001 was vaccinated IM with the first dose of VARIVAX (Merck) on the thigh (lot # 639486/0571L). On 06-JUN-2007 the patient was vaccinated with the second dose of VARIVAX (Merck) on the arm. On 01-JUN-2010 the patient experienced classic case though number of lesions only about 50 (attenuated). On 02-JUN-2010 the patient sought medical attention in office and diagnosed clinically as varicella. There were no relevant diagnostic tests or laboratory data. The status of the patient was unknown. Additional information is not expected.
Pain in all arms and legs, muscle spasms, muscle twitching, tingling in extremities
She said she had some other patients who had similar symptoms/my neuropathy in my fingers flared up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (She said she had some other patients who had similar symptoms/my neuropathy in my fingers flared up) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Neuropathy.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (She said she had some other patients who had similar symptoms/my neuropathy in my fingers flared up) (seriousness criterion medically significant). At the time of the report, NEUROPATHY PERIPHERAL (She said she had some other patients who had similar symptoms/my neuropathy in my fingers flared up) outcome was unknown.            The concomitant medications were not reported. The treatment information was not provided.  Company Comment: Very limited information regarding this event has been provided at this time. Further information has been requested.; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested.
Diagnosed with CML few months ago and taking Dasatinib daily with great response and normalized WBCs. Had second dose of Pfizer vaccine 2/2. Blood work on 2-5 WBCs 150K and 2/6 bilateral blood clots in legs which then became pulmonary blood clots.
Pt experienced stomach cramps, dizziness for 3 days. No neurological, musculoskeletal side effects. After receiving influenza vaccine, lot #U1268AA. Had stomach cramps, dizziness for three days. No neurological/musculoskeletal side effects. At the time, the vaccine was under investigation and held for immunizations. Patient was doing OK afterwards. No sequelae. No allergy.
REPORTS HIS LEFT SIDE FELT 'WEIRD' AFTER RECEIVING YELLOW FEVER VACCINE; REPORTS ONE TO TWO DIZZY EPISODES DAILY SINCE VACCINATED, NO FEVER, + NAUSEA, NO VOMITING; ONE EPISODE OF DIARRHEA 3 DAYS AFTER VACCINATION; H/A 6 DAYS AFTER VACCINATION - RXED W/ NSAID; SEEN BY PCP 5 DAYS AFTER VACCINATION AND IN ED 6 DAYS AFERT VACCINATION; HAS CONTINUED TO ATTEND SCHOOL
patient's site of injection at her arm started to swollen and become red . hot to touch  . so she went to her doctor on Monday , dr told her that this is cellulitis as a result from the flu shot , so he gave her antibiotic
This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 61-year-old female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On 11th December 2018, unknown after receiving SHINGRIX, the patient experienced influenza-like symptoms, pain and shivers. On an unknown date, the outcome of the influenza-like symptoms, pain and shivers were not recovered/not resolved. It was unknown if the reporter considered the influenza-like symptoms, pain and shivers to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported but it could be 60 or 61 years. The patient had a shot of SHINGRIX vaccine and had no issues but on the day of reporting the patient felt horrible with flu like symptoms. The patient experienced flu like side effects as aches, pain and shivers. The reporter asked that how long do the flu like side effects would lasts.
Pt received her COVID19 Moderna vaccine today. While sitting in observation she reported a headache. BP 140/90, 125/80. HR 72. O2Sat 97%. Pt was offered EMS evaluation however she refused.
This spontaneous report as received from a pharmacist refers to a newborn male patient of unknown age. On 27-OCT-2012 18:58, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot # were involved and the lot # were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot # the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Rash under the skin that is itchy; Rash under the skin that is itchy; This is a spontaneous report from a contactable nurse (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142), via an unspecified route of administration on the left arm on 29Dec2020 09:00 at a single dose for COVID-19 immunization. Medical history included ongoing blood pressure high, ongoing diabetic, and metal and copper allergies. Concomitant medication included unspecified regular medications. No other vaccines were administered on the same date. No vaccinations were received four weeks prior. On 10Jan2021 23:00, the patient reported that she broke out in a rash under her skin that was so itchy. She noticed the rash around 11PM and had been taking Benadryl around the clock. She can still see the rash on her skin, it was not raised or bumpy, but it itches like crazy. She clarified the rash was located on both of her arms, trunk, chest, back, and neck. She believed the COVID-19 vaccine was related to the rash that was itchy that she was having. She cannot think of anything she has done differently to cause this itching. It started Sunday and at the time of reporting, it was Thursday and she still had it. She stated she was trying to go to the doctor to be looked at, but no one called her back. She has been taking Benadryl around the clock from the beginning of when it was needed. It seemed like the Benadryl has not phased her at all as she was wide awake. The next dose was scheduled for Monday 18Jan2021 and she did not know if she wanted to get the second dose of the vaccine. The vaccine was given at a hospital, not military facility. The adverse events did not require a visit to the emergency room or to the physician's office. The patient underwent lab tests and procedures which included rapid COVID test: negative on 13Jan2021. Outcome of the events was recovering. The events were reported as non-serious and related to the suspect drug.
GAVE A DOSE ONE DAY BEFORE THEIR 5TH BIRTHDAY.  NO ADVERSE EVENT NOTED.  RECIEVED SECOND DOSE WITHOUT ISSUE.
Prior to injection, patient stated she was nervous and gets dizzy with shots and cries, but will be fine.  Consent given and injection given in L arm.  Second after injection, patient stated that she wants to be a pediatrician when she grows up, and then said "Wait! I am not making sense...", and her head dropped back slightly and the nurse held her head and asked the monitor for help.  Both nurses carefully lowered patient to the ground without incident.  She started jerking and then started crying.  Others arrived and began taking her blood pressure and provided ice packs.  The rapid response team was called, and they checked vitals  which were all WNL.  After approximately 20 minutes, patient felt good enough to stand on her own.  Approximately 20 minutes after that patient felt good enough to leave under her own power.
Numbness in arm and extremities, particularly the right side, consistent headaches, body inflammation, sharp pain deep in my legs, arms, and abdomen that feel like they are in the veins,  ongoing metallic or strange taste in my mouth,  loss of feeling in the fingers of my right hand   These symptoms are ongoing.
Pfizer-BioNTech COVID-19 Vaccine.  Mild headache, mild low back pain, and fever started 20-24 hours after vaccine was given. Peak temp was 101.4F about 32 hours after vaccine was given. I did not take any medication for it (no acetaminophen, no NSAIDs). All symptoms resolved on their own within 48 hours. Temperature was 98.9F at 44 hours after vaccine.
This non-valid spontaneous report was received from a licensed practical nurse refers to unknown number of patients of unknown age and gender. The patients concurrent conditions, medical history, drug reactions and allergies were not reported. The patients concomitant medication included Diluent MRK Inj used to reconstitute M-M-R II, which did not undergo a temperature excursion. On an unknown date, patients were vaccinated with improperly stored GARDASIL 9 (dose, units, frequency, route, lot# and expiration date not reported) and M-M-R II (dose, units, frequency, route, lot# and expiration date not reported). The administered vaccines had temperature excursion from 0 degree Celsius (C) to 1 C (1.23 C) and from 9 C to 25 C (9.63 C) for an unknown time frame as recorded by digital data logger (Incorrect product storage). The administered vaccines had no previous temperature excursion. No adverse effects reported in any patients. No product quality complaint involved. This is a non-valid report due to lack of patient identifiers. Follow-up information has been received on 25-JUN-2018 from a physician. This report refers to a 4 year old female patient. On 24-MAR-2018, the patient was vaccinated with improperly stored second dose of M-M-R II (Lot # M045394, Expiration date: 14-NOV-2018, Route: Subcutaneous, Site: Right thigh), second dose of VARIVAX (Lot # N017699, Expiration date: 09-JUN-2019, Route: Subcutaneous, Route: Right thigh) and KINRIX (Lot # 75747, Expiration date unknown, Route: Intramuscular, Route: Left thigh) for prophylaxis. The temperature excursion occurred as a result of a reading from a digital data logger.
Right arm swollen, red, and hot to the touch.  Patients arm also had a tight knot under skin.  Dr. advised on 4-11-09 that patient should take BENADRYL
The flu shot was very painful. The pain on the shot area was so bad that I couldn't raise my arm and lasted a few days. It got a little better, but still felt pain when I raised my arm. It lasted for 2-months and still hadn't got better. Not it got worse. It's been 4-months and I can't even move my arm to left side to close my button of my pants. It's very painful to raise my arm. I can't move my arm around without suffering a lot of pain.
mild headache + fatigue; mild headache + fatigue; 4 year old female received 1st dose of Pfizer COVID 19 Vaccine. They gave the child the orange cap formulation, Pfizer COVID 19 Vaccine instead of the maroon cap; 4 year old female received 1st dose of Pfizer COVID 19 Vaccine. They gave the child the orange cap formulation, Pfizer COVID 19 Vaccine instead of the maroon cap; Vaccine Name: Proquad, Date: 01Aug2022/Vaccine Name: Kinrix, Date: 01Aug2022; Vaccine Name: Proquad, Date: 01Aug2022/Vaccine Name: Kinrix, Date: 01Aug2022; This is a spontaneous report received from contactable reporter(s) (Nurse) from medical information team, Program ID: (159558).  A 4-year-old female patient received BNT162b2 (BNT162B2), on 01Aug2022 as dose 1 (orange cap), single (Lot number: FL8094, Expiration Date: 31Aug2022) at the age of 4 years intramuscular, in left arm for covid-19 immunisation; measles vaccine live (enderS-edmonston), mumps vaccine live, rubella vaccine live (wistar ra 27/3), varicella zoster vaccine live (oka/merck) (PROQUAD), on 01Aug2022 as dose number unknown, single (Lot number: W004028) subcutaneous, in left arm for immunisation; diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (KINRIX), on 01Aug2022 as dose number unknown, single (Lot number: H9917) intramuscular, in right arm for immunisation. The patient's relevant medical history included: "COVID", start date: 17Jul2022, stop date: 17Jul2022, notes: Brief illness-totally resolved prior to visit. There were no concomitant medications.  The following information was reported: PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (non-serious), OVERDOSE (non-serious) all with onset 01Aug2022, outcome "unknown" and all described as "4 year old female received 1st dose of Pfizer COVID 19 Vaccine. They gave the child the orange cap formulation, Pfizer COVID 19 Vaccine instead of the maroon cap"; PRODUCT USE ISSUE (non-serious), OFF LABEL USE (non-serious) all with onset 01Aug2022, outcome "unknown" and all described as "Vaccine Name: Proquad, Date: 01Aug2022/Vaccine Name: Kinrix, Date: 01Aug2022"; HEADACHE (non-serious), FATIGUE (non-serious), outcome "unknown" and all described as "mild headache + fatigue".  Additional information: It was reported that the patient had mild headache and fatigue for 1-2 days after administration.  Follow-Up (23Aug2022): Follow-up attempts are completed. No further information is expected.  Follow up (06Sep2022): This is a spontaneous follow-up report from a contactable Physician. This Physician reported in response to HCP follow-up letter sent that included: Updated Information Included: Reporter Information, facility information, dosage regimen, RMH and New adverse events.
In late February I developed a sinus infection and cough, the cough turned into over time where I could not breath. I started taking Mucinex and yesterday when I woke I could not walk two steps and breath so I went to the ER and  I was told I had cloudy lungs.  I was diagnosed with Pneumonia.
On 4/4 and my feet all the way to my knees have swollen up for the last three and a half weeks, I lost all the toenails on my left foot, my other foot the big toe nail died and all the bones in my body hurt and are sore and feels like I've been beaten. The tops of my feet are bruised and my knuckles are seriously bruised across the finger and bones. I've had liver test, heart test, blood clots test and nothing was found, all the tissue in my body is tender and I have osteopenia, PBD positive,
Developed rash on 04/09/2014 (diagnosed as shingles on 04/14/2014). Then, 04/13/2014, developed flu symptoms of fever, body ache, headache, and was diagnosed as Influenza B positive on 04/14/2014.
This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date in November 2018, between 02-NOV-2018 and 16-NOV-2018, the patient was vaccinated with a dose of improperly stored varicella virus vaccine live (Oka/Merck) subcutaneously (dose was not provided, lot# R017640, expiration date 20-JUN-2020) for prophylaxis. The vaccine was reconstituted with properly stored sterile diluent. No adverse effect. The digital data logger was involved. The vaccine experienced temperature excursion between 15 degrees Fahrenheit to 46 degrees Fahrenheit (15.1 degrees Fahrenheit) for 1 hour. There were no previous temperature excursions. This is one of several reports from the same reporter. Sender's Comments: US-009507513-1811USA009255: US-009507513-1811USA009256: US-009507513-1811USA009257: US-009507513-1811USA009258: US-009507513-1811USA009259: US-009507513-1811USA009260: US-009507513-1811USA009261: US-009507513-1811USA009142.
body aches; eyes burned; dizzy; fatigued; sore in her arm (injection site); This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)), MYALGIA (body aches) and EYE IRRITATION (eyes burned) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain. Concomitant products included MULTIVITAMINS [VITAMINS NOS] for Supplementation therapy.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)) and EYE IRRITATION (eyes burned). On 07-Feb-2021, the patient experienced MYALGIA (body aches). At the time of the report, DIZZINESS (dizzy), FATIGUE (fatigued), VACCINATION SITE PAIN (sore in her arm (injection site)), MYALGIA (body aches) and EYE IRRITATION (eyes burned) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication nor treatment provided
Patient was given Moderna vaccine which is unauthorized for anyone under 18 years of age.  Supervisor, PCP and VFC coordinators notified to escalate this.
This spontaneous report as received from a medical assistant refers to a 41 year old patient of unknown gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 21-JUL-2016, the patient was vaccinated with a pediatric dose of RECOMBIVAX HB (lot # L040458, expiration date, exact dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effect was reported. No product quality complaint (PQC) was involved. Additional information has been requested.
I started with itchy bumps on my legs and now I'm getting them on my arms. They pop out and itch intensely. I used hydrocortisone and Benadryl and didn't work. My doctor gave me a prescription steroid cream. After the 4th dose I had a similar reaction but not as intense. The Dermatologist felt it was a reaction to a shot. The rash seems to be not as bad in terms of the itchness but I continue to get it in different places.
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperature and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who had been administered dose of GARDASIL on 20-MAY-2013 (lot number: 672232/1495AA; exp date: 22-AUG-2014) (dose, frequency, route and site of administration were not reported). No adverse event was reported. This is one of the reports from the same source. Additional information is not expected.
Sore arm from the first shot; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 17Jan2021 (Lot Number: EL3246) as dose 1, single for COVID-19 immunisation.  The patient's medical history and concomitant medications were not reported.  On an unspecified date, the patient experienced sore arm from the first shot. The outcome of the event was unknown.   No follow-up attempts are possible. No further information is expected.
48 hours (Feb 26) after receiving the shot, I had anaphylaxis symptoms... red blotches around mouth, swelling face, swelling lips, ants-crawling feeling on face, neck and scalp. Went to Urgent Care, given benadryl and steroid shot. Rx Prednisone 20 mg x2, 5 days. Anaphylaxis happened again the next day (Feb 27) just prior to taking the first prednisone. Went back to Urgent Care, another shot. Meds kept full on allergic reactions at bay on Monday and Tuesday. Had swelling face, lips and tongue happen in Primary Care office on March 3, received another shot and increased prednisone rx to 30 mg x2, with taper. On March 5, happened again, went to ER, where doc changed timing of prednisone to 60 mg all in one dose. All in conjunction with hydroxyzine 25 mg every 12 hours and 50 mg of benadryl every six hours.  Situation continues with mild swelling, itchy sensations happening just before it is time to take new meds .
2 days after receiving the flu shot and the covid bivalent booster, I was walking to my normal martial arts practice and noticed I was unusually winded just from the walk (10 minutes). This would persist for about a month anytime I would do any physical exercise. I also felt like my heart beat would sometimes be irregular. I suspected myocarditis based on some of the news I'd read and also saw that it was mild and people would completely recover. So I simply refrained from exercising for a month and attempt to make an appointment with my primary heathcare physician to get it checked out, but after trying for two months I couldn't make an appointment.
slight fever; Felt little poorly for 24 hours; This is a spontaneous report from a contactable consumer. A 58-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on 20Jan2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced slight fever and felt little poorly for 24 hours on an unspecified date. It was reported that patient had the COVID second dose vaccine on Tuesday and you know the first dose patient did not have significant side effect, patient had slight fever and just felt little poorly for 24 hours but the second dose has been quite doozy, patient had experienced the high fever for 2 days, vomiting and nausea and the vomiting stopped 24 hours ago but still have significant nausea and a headache that is from 1 to 10 it's a 9 and patient had it for you know, It started about 24 hours after patient took the vaccine, her question was you know, when she reached out to her doctor and she had me take a COVID test because she have not heard the vomiting and you know nausea to be one of the common side effects of the COVID Vaccine so I took a COVID test yesterday, and she got it back this morning and it is negative so thank god she didn't have that but she was wondering how, A was the nausea, vomiting and the severe headaches normal if so how long can she expect these symptoms to occur and is there anything she can do, can she take something for this, she had been very reluctant to take anything because they, you know she hear that you did not want to take things because you want to immune, you want to immune system it to work. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 12Feb2021. Outcome of the event slight fever was recovering and outcome of the other event was unknown.